HMGB1-induced ILC2s activate dendritic cells by producing IL-9 in asthmatic mouse model

  • 类型:
  • 作者:Jie Wan, Lan Huang, Xiaoyun Ji, Shun Yao, Mohamed Hamed Abdelaziz, Wei Cai, Huixuan Wang, Jianjun Cheng, Kesavan Dineshkumar, Vasudevan Aparna, Zhaoliang Su, Shengjun Wang, Huaxi Xu
  • 期刊:CELLULAR IMMUNOLOGY
  • 阅读原文

Asthma is a disease of the respiratory system that is commonly considered a T-helper 2 (Th2) cell-associated inflammatory disease. Group 2 innate lymphoid cells (ILC2s) promote the inflammatory responses in asthma by secreting type 2 cytokines. Interleukin (IL)-9 also serves as a promoting factor in asthma and it is well known that ILC2s have an autocrine effect of IL-9 to sustain their survival and proliferation. However, the specific role of ILC2-derived IL-9 in asthma remains unclear. HMGB1 (High-Mobility Group Box-1) is a nuclear protein, and Previous studies have shown that HMGB1 can regulate the differentiation of T-helper cells and participate in the development of asthma. But whether HMGB1 can regulate the innate lymphocytes in the pathological process of asthma is unknown. In this study we have shown increased presence of HMGB1 protein in the lung of mice with asthma, which was associated with increased secretion of IL-9 by ILC2s. This led to the activation of dendritic cells (DCs) that can accelerate the differentiation of Th2 cells and worsen the severity of asthma. Taken together, our study provides a complementary understanding of the asthma development and highlights a novel inflammatory pathway in the pathogenesis of asthma.

文章引用产品列表